Effects of 2-bromo-alpha-ergocryptine on beta-endorphin-induced growth hormone, prolactin and luteining hormone release in urethane anesthetized rats.
D000818:Animals; D001971:Bromocriptine / Q000494:pharmacology*; D004723:Endorphins / Q000008:administration & dosage / Q000037:antagonists & inhibitors*; D013006:Growth Hormone / Q000378:metabolism*; D007276:Injections, Intraventricular; D007986:Luteinizing Hormone / Q000378:metabolism*; D008297:Male; D011388:Prolactin / Q000378:metabolism*; D051381:Rats
D004723:Endorphins; D001971:Bromocriptine; D011388:Prolactin; D007986:Luteinizing Hormone; D013006:Growth Hormone